Ralph Snyderman has been awarded the 2007 Leadership in Personalized Medicine Award from the Personalized Medicine Coalition. Snyderman is chancellor emeritus at Duke University and founder and chairman of Proventys. Snyderman has been a Howard Hughes Medical Institute investigator, a Duke University researcher, and he was senior VP at Genentech.
The Will Rogers Institute will give its annual prize for Outstanding Contributions to Lung Research to Francis Collins, director of the National Human Genome Research Institute, on Dec. 6. The institute said it selected Collins for his research that led to the identification of the CFTR gene that is linked to lung diseases in some of its mutations.
Gene Express has appointed David Sidransky and Michael Liebman to its scientific advisory board. Sidransky is director of the Head and Neck Cancer Research Division at Johns Hopkins University’s School of Medicine. He also has been a director at ImClone and he has served on scientific advisory boards at MedImmune, Amgen, and Veridex, and he is vice chairman at Alfacell.
Liebman is managing director of Strategic Medicine and is a senior institute fellow at the Windber Research Institute. He was director of computational biology and biomedical informatics at the Abramson Family Cancer Research Institute at the University of Pennsylvania. Liebman also was global head of computational genomics at Roche Pharmaceuticals, director of bioinformatics and pharmacogenomics at Wyeth Pharmaceuticals, and he was director of genomics for Vysis.